| pubmed-article:20234364 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C0257685 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C0439851 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C1552596 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C1947931 | lld:lifeskim |
| pubmed-article:20234364 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
| pubmed-article:20234364 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:20234364 | pubmed:dateCreated | 2010-3-31 | lld:pubmed |
| pubmed-article:20234364 | pubmed:abstractText | Pre-clinical studies have demonstrated synergistic anti-tumour effects of chemotherapy (CT) and zoledronic acid (ZOL). Within the AZURE trial, designed to determine whether the addition of ZOL to neoadjuvant therapy improves disease outcomes, a subgroup received neoadjuvant CT. We report a retrospective evaluation comparing pathological response in the primary tumour between treatment groups. | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20234364 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20234364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20234364 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20234364 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:20234364 | pubmed:issn | 1532-1827 | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:WheatleyDD | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:ColemanR ERE | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:CameronDD | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:BellRR | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:RitchieDD | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:GilMM | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:MarshallS JSJ | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:WinterM CMC | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:DodwellDD | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:KeaneM MMM | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:ThorpeHH | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:BurkinshawRR | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:Passos-Coelho... | lld:pubmed |
| pubmed-article:20234364 | pubmed:author | pubmed-author:AZURE... | lld:pubmed |
| pubmed-article:20234364 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20234364 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:20234364 | pubmed:volume | 102 | lld:pubmed |
| pubmed-article:20234364 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20234364 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20234364 | pubmed:pagination | 1099-105 | lld:pubmed |
| pubmed-article:20234364 | pubmed:dateRevised | 2011-7-27 | lld:pubmed |
| pubmed-article:20234364 | pubmed:meshHeading | pubmed-meshheading:20234364... | lld:pubmed |
| pubmed-article:20234364 | pubmed:meshHeading | pubmed-meshheading:20234364... | lld:pubmed |
| pubmed-article:20234364 | pubmed:meshHeading | pubmed-meshheading:20234364... | lld:pubmed |
| pubmed-article:20234364 | pubmed:meshHeading | pubmed-meshheading:20234364... | lld:pubmed |
| pubmed-article:20234364 | pubmed:meshHeading | pubmed-meshheading:20234364... | lld:pubmed |
| pubmed-article:20234364 | pubmed:meshHeading | pubmed-meshheading:20234364... | lld:pubmed |
| pubmed-article:20234364 | pubmed:meshHeading | pubmed-meshheading:20234364... | lld:pubmed |
| pubmed-article:20234364 | pubmed:meshHeading | pubmed-meshheading:20234364... | lld:pubmed |
| pubmed-article:20234364 | pubmed:meshHeading | pubmed-meshheading:20234364... | lld:pubmed |
| pubmed-article:20234364 | pubmed:meshHeading | pubmed-meshheading:20234364... | lld:pubmed |
| pubmed-article:20234364 | pubmed:meshHeading | pubmed-meshheading:20234364... | lld:pubmed |
| pubmed-article:20234364 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20234364 | pubmed:articleTitle | The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. | lld:pubmed |
| pubmed-article:20234364 | pubmed:affiliation | Academic Unit of Clinical Oncology, Weston Park Hospital, University of Sheffield, Sheffield, UK. r.e.coleman@sheffield.ac.uk | lld:pubmed |
| pubmed-article:20234364 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20234364 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20234364 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20234364 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20234364 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20234364 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20234364 | lld:pubmed |
